Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445729 · ClinicalTrials.gov registry record · NA
Impact of Timing of Wound Dressing Removal After Cesarean Section
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 869
- Enrollment target
NCT02445729: Completed NA study, sponsored by The University of Texas Medical Branch, Galveston.
NCT02445729 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 869 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445729, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 869 participants
- Enrollment target
Study Summary
The purpose of this study is to assess wound healing at 24 vs 48 hours post cesarean delivery with a modified 1-day ASEPSIS score.
Interventions
- OTHER Dressing removal at 24 hours
- OTHER Dressing removal at 48 hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 869 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-01-31 |
| Phase | NA |
What the finished NCT02445729 record still lists
NCT02445729 is an interventional study that assigns participants to a tested intervention. The registered 869 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 2 interventions - of which Dressing removal at 24 hours is the first listed.
NCT02445729 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445729 about?
NCT02445729 is a clinical study titled "Impact of Timing of Wound Dressing Removal After Cesarean Section". The purpose of this study is to assess wound healing at 24 vs 48 hours post cesarean delivery with a modified 1-day ASEPSIS score.
What is the current status of trial NCT02445729?
This trial is currently completed. It is a NA study. The enrollment target is 869 participants. The study started on 2015-03. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT02445729?
The interventions under investigation include: Dressing removal at 24 hours (OTHER), Dressing removal at 48 hours (OTHER).
Who is sponsoring clinical trial NCT02445729?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02445729's enrollment target sits among peer trials
869 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia